Mesa Laboratories, Inc. (MLAB) to Issue Quarterly Dividend of $0.16 on September 16th

Mesa Laboratories, Inc. (NASDAQ:MLABGet Free Report) declared a quarterly dividend on Monday, July 8th, Wall Street Journal reports. Stockholders of record on Friday, August 30th will be paid a dividend of 0.16 per share by the medical instruments supplier on Monday, September 16th. This represents a $0.64 annualized dividend and a dividend yield of 0.69%. The ex-dividend date is Friday, August 30th.

Mesa Laboratories has a dividend payout ratio of 7.4% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Mesa Laboratories to earn $7.29 per share next year, which means the company should continue to be able to cover its $0.64 annual dividend with an expected future payout ratio of 8.8%.

Mesa Laboratories Price Performance

MLAB stock opened at $92.78 on Wednesday. The company has a debt-to-equity ratio of 0.58, a quick ratio of 1.86 and a current ratio of 0.37. The firm has a 50 day simple moving average of $103.17 and a 200 day simple moving average of $102.25. Mesa Laboratories has a 52 week low of $82.86 and a 52 week high of $145.46.

Mesa Laboratories (NASDAQ:MLABGet Free Report) last posted its quarterly earnings results on Wednesday, June 5th. The medical instruments supplier reported $2.25 earnings per share for the quarter. Mesa Laboratories had a negative net margin of 117.61% and a positive return on equity of 10.10%. The firm had revenue of $58.90 million for the quarter. On average, equities analysts forecast that Mesa Laboratories will post 6.91 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, Evercore ISI reduced their target price on shares of Mesa Laboratories from $120.00 to $106.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 2nd.

Get Our Latest Report on Mesa Laboratories

About Mesa Laboratories

(Get Free Report)

Mesa Laboratories, Inc develops, manufactures, and sells life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. It operates in four segments: Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions.

Read More

Dividend History for Mesa Laboratories (NASDAQ:MLAB)

Receive News & Ratings for Mesa Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories and related companies with's FREE daily email newsletter.